Paradiem LLC Sells 30,524 Shares of Docusign Inc. $DOCU

Paradiem LLC reduced its stake in shares of Docusign Inc. (NASDAQ:DOCU) by 73.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,820 shares of the company’s stock after selling 30,524 shares during the quarter. Paradiem LLC’s holdings in Docusign were worth $780,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Palogic Value Management L.P. grew its stake in Docusign by 2.2% during the first quarter. Palogic Value Management L.P. now owns 5,438 shares of the company’s stock worth $443,000 after buying an additional 117 shares in the last quarter. Centaurus Financial Inc. raised its position in shares of Docusign by 2.6% in the 2nd quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after buying an additional 136 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Docusign by 31.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 595 shares of the company’s stock worth $46,000 after acquiring an additional 142 shares during the period. Total Wealth Planning & Management Inc. boosted its position in shares of Docusign by 4.8% during the 2nd quarter. Total Wealth Planning & Management Inc. now owns 3,170 shares of the company’s stock worth $247,000 after acquiring an additional 146 shares in the last quarter. Finally, Mitchell & Pahl Private Wealth LLC increased its stake in Docusign by 0.7% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company’s stock valued at $1,544,000 after acquiring an additional 149 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on DOCU. Evercore ISI cut their target price on Docusign from $92.00 to $80.00 and set an “in-line” rating for the company in a research note on Friday, December 5th. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a report on Wednesday, December 17th. Zacks Research downgraded Docusign from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th. Bank of America decreased their target price on Docusign from $102.00 to $82.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Finally, Wells Fargo & Company lowered their target price on Docusign from $85.00 to $75.00 and set an “equal weight” rating for the company in a research note on Friday, December 5th. Six investment analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $86.80.

Docusign Stock Up 0.5%

Shares of DOCU stock opened at $69.97 on Friday. The firm has a market capitalization of $14.01 billion, a P/E ratio of 48.93, a P/E/G ratio of 3.51 and a beta of 0.98. Docusign Inc. has a twelve month low of $63.41 and a twelve month high of $99.30. The stock’s fifty day simple moving average is $69.12 and its 200 day simple moving average is $73.44.

Insider Activity

In other news, Director James A. Beer sold 450 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $68.54, for a total transaction of $30,843.00. Following the sale, the director directly owned 14,478 shares in the company, valued at approximately $992,322.12. The trade was a 3.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Teresa Briggs sold 365 shares of the company’s stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $69.19, for a total value of $25,254.35. Following the completion of the transaction, the director directly owned 8,805 shares of the company’s stock, valued at $609,217.95. This represents a 3.98% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 87,542 shares of company stock valued at $6,097,905. 1.01% of the stock is currently owned by company insiders.

Docusign Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.